European Urology published a clinical update in Research Highlights on 03 Feb 2026. The item focuses on Re: Durvalumab in Combination with BCG for BCG-naive, High risk, Non-muscle-invasive Bladder Cancer (POTOMAC): Final Analysis of a Randomised, Open-label, Phase 3 Trial. Review the original article for the full source wording and details.
European Urology published a clinical update in Research Highlights on 03 Feb 2026.
The item focuses on Re: Durvalumab in Combination with BCG for BCG-naive, High risk, Non-muscle-invasive Bladder Cancer (POTOMAC): Final Analysis of a Randomised, Open-label, Phase 3 Trial.
Review the original article for the full source wording and details.